Accessibility Menu
Vaso logo

Vaso(OTC) VASO

Market Cap$47.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-92%
5 Year+387%
1 Year+118%
1 Month+35%
$0.28
+2.61%
+0.01Today
Vaso last closing stock price
MetricPriceDate
Last closeUSD 0.272026-08-14
Vaso stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.1%USD 0.262026-08-07
1 month+35.01%USD 0.202026-07-15
3 month+15.92%USD 0.232026-05-15
Year to date+53.23%USD 0.172025-12-31
1 year+117.53%USD 0.122025-08-14
3 year-10.67%USD 0.302023-08-15
5 year+387.27%USD 0.062021-08-13
Since inception-91.59%USD 3.191992-06-15

Vaso Financials at a Glance

Market Cap

$47.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$80.22M

Net Income (TTM)

$2.79M

EPS (TTM)

$0.02

P/E Ratio

26.80

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Price

$0.28

Volume

179,801

Open

$0.27

Previous Close

$0.28

Daily Range

$0.27 - $0.28

52-Week Range

$0.11 - $0.28

Estimated Earnings Date

Aug 14, 2026

VASO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vaso

Vaso helps hospitals manage patient data and medical equipment sales. Its systems support doctors in diagnosing heart disease and monitoring vital signs. The company’s services make healthcare operations more efficient for providers and patients.

What’s in the Vaso Toolbox?

  • IT segment (47.7% of revenue): Delivers network, security, and data management for hospitals and clinics.
  • Professional Sales Service (50% of revenue): Sells and supports GE HealthCare imaging equipment to U.S. healthcare providers.
  • Medical Devices (2.7% of revenue): Designs and sells heart monitors, blood pressure recorders, and wireless patient monitoring systems.
  • Diagnostic Software: Provides cloud-based tools for analyzing heart and blood pressure data, used by clinics and hospitals.
  • Non-Invasive Therapy Systems: Offers outpatient devices for treating heart disease without surgery.

Growth Moves: Vaso’s Playbook

  • Sold its healthcare IT business to Nano-X Imaging in November 2025 for up to $800,000.
  • Extended exclusive GE HealthCare sales agreement through December 2030.
  • Expanded cloud-based software and managed network services since 2024.
  • Increased U.S. focus as China equipment sales declined after 2023.
  • Continues to seek new partnerships and product innovations.

Why Vaso Gets Noticed

Vaso combines proprietary medical devices, managed IT, and exclusive sales for GE HealthCare. Its direct sales teams cover the U.S. and China, with global distribution partners. The company holds patents and regulatory approvals in major markets.

Five Things You Need to Know

  • Revenue was $89.1 million in 2025, up 2.7% from 2024.
  • Professional Sales Service segment contributed 49.6% of 2025 revenue.
  • Net income reached $1.6 million in 2025, up 65% from 2024.
  • Cash flow from operations was $9.3 million in 2025.
  • U.S. sales made up 97.3% of total revenue in 2025.

Bottom Line

Vaso has evolved by blending medical device innovation, IT services, and exclusive sales partnerships. Its diversified model helps it adapt to changing healthcare needs and market conditions.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

282

CEO

Jun Ma, PhD

Website

www.vasocorporation.com

Headquarters

Plainview, NY 11803, US

VASO Financials

Key Financial Metrics (TTM)

Gross Margin

64.80%

Operating Margin

3.78%

Net Income Margin

3.48%

Return on Equity

9.91%

Return on Capital

5.60%

Return on Assets

3.37%

Earnings Yield

3.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$47.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

176.00M

Volume

179.80K

Avg. Volume

167.14K

Financials (TTM)

Gross Profit

$51.98M

Operating Income

$3.03M

EBITDA

$424.00K

Operating Cash Flow

-$2.79M

Capital Expenditure

-$963.00K

Free Cash Flow

-$3.75M

Cash & ST Invst.

$21.97M

Total Debt

$2.40M

Vaso Performance Analysis

Vaso annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 79,294,0004.9%
20232023-12-31USD 81,024,0002.2%
20242024-12-31USD 86,767,0007.1%
20252025-12-31USD 89,096,0002.7%
Vaso sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3013.5%
Q42025-12-3119.3%
Q12026-03-31-28.4%
Q22026-06-30-42.2%
Vaso annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.0684.3%
20232023-12-31USD 0.03-57.7%
20242024-12-31USD 0.01-80.3%
20252025-12-31USD 0.0164.8%
Vaso sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301009.1%
Q42025-12-31-36.0%
Q12026-03-31-178.1%
Q22026-06-30196.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$11.19M

-43.9%

Gross Profit

$8.89M

-24.7%

Gross Margin

79.46%

N/A

Market Cap

$47.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$167.26K

N/A

Employees

282

N/A

Net Income

$840.00K

+526.4%

EBITDA

$1.09M

+3025.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$21.97M

-13.2%

Total Debt

$2.40M

+11.6%

Accounts Receivable

$22.64M

+69.0%

Inventory

$827.00K

-14.3%

Long Term Debt

$980.00K

-10.1%

Short Term Debt

$1.42M

+34.0%

Return on Assets

3.37%

N/A

Return on Invested Capital

5.78%

N/A

Free Cash Flow

-$13.08M

-2211.7%

Operating Cash Flow

-$12.63M

-2130.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVLPFNova Leap Health Corp.
$0.35+4.45%
RAPHRaphael Pharmaceutical Inc.
$1.40+0.00%
PYNKFPerimeter Medical Imaging AI, Inc.
$0.29+7.51%
EMITFElbit Imaging Ltd.
$1.60+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.61-0.02%
SPCXSpace Exploration Technologies
$146.23+0.04%
IPSTIp Strategy
$7.39+2.36%
NVDANvidia
$225.01-0.00%

Questions About VASO

What is the current price of Vaso?

Vaso is trading at $0.28 per share.

What is the 52-week range for Vaso?

Over the past 52 weeks, Vaso has traded between $0.11 and $0.28.

How much debt does Vaso have?

As of the most recent reporting period, Vaso reported total debt of $1.79M.

How much cash does Vaso have on hand?

Vaso reported $38.29M in cash and cash equivalents in its most recent financial results.

What is Vaso’s dividend yield?

Vaso does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services